YM348 is a potent and orally bioavailable agonist selective for the 5-HT2C receptor, exhibiting high binding affinity (Ki = 0.89 nM). It is a valuable research tool for investigating the role of 5-HT2C receptors in neuropsychiatric disorders, utilized in both in vitro binding assays and in vivo behavioral studies.